Fundz

Oculis Expands Its Executive Leadership Team and Appoints

PUBLIC · OCSSep 11, 2023

Position

Chief Commercial Officer

Company

Oculis Holding AG

Rebecca Weil
rebecca.weil@oculis.com
LausanneBiotechnologyHealth CareTherapeuticsBiopharma

Description

ZUG, Switzerland and BOSTON, Sept. 11, 2023 -- Oculis Holding AG , a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the appointment of global commercial executive with extensive ophthalmology experience, Rebecca Weil, to the role of Chief Commercial Officer. In this key role, Ms

Quick answer

Oculis Expands Its Executive Leadership Team and Appoints (September 11, 2023). Oculis Holding AG is based in Lausanne, Vaud, Switzerland.

What did Oculis Holding AG announce on September 11, 2023?
ZUG, Switzerland and BOSTON, Sept. 11, 2023 -- Oculis Holding AG , a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the appointment of global commercial executive with extensive ophthalmology experience, Rebecca Weil, to the role of Chief Commercial Officer.
What does Oculis Holding AG do?
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care.
Where is Oculis Holding AG based?
Oculis Holding AG is based in Lausanne, Vaud, Switzerland.
Which similar companies made leadership changes around the same time?
Madrigal Pharmaceuticals (September 14, 2023), Hansa Biopharma (September 1, 2023), Royalty Pharma plc (September 21, 2023) and Pfizer (September 28, 2023) also announced leadership changes within 45 days of Oculis Holding AG.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Oculis Holding AG, and when

A new leader at Oculis Holding AG brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Oculis Holding AG raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Oculis Holding AG, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oculis Holding AG. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Oculis Holding AG

Location

Lausanne, Vaud, Switzerland

About

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. The company is focused on advancing late-stage clinical trials for treating conditions such as Dry Eye Disease (DED) and Diabetic Macular Edema (DME).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Oculis Holding AG changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Rebecca
Likely contact at this company
••••••••@••••••••

See Rebecca's verified email →

Björn
Likely contact at this company
••••••••@••••••••

See Björn's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Oculis Holding AG's next move

Learn about Strategic plan

Oculis Holding AG changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.